Hyderabad Telangana, India

Aggi Ramireddy Bommareddy

USPTO Granted Patents = 4 

Average Co-Inventor Count = 5.2

ph-index = 1


Location History:

  • Telangana, IN (2020)
  • Hyderabad, IN (2014 - 2022)

Company Filing History:


Years Active: 2014-2022

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Aggi Ramireddy Bommareddy: Innovator in Pharmaceutical Patents

Introduction

Aggi Ramireddy Bommareddy is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, holding a total of four patents. His work primarily focuses on innovative formulations and processes that enhance the efficacy of various medications.

Latest Patents

Among his latest patents is the development of polymorphic forms of bictegravir and its sodium salt. This patent provides crystalline forms of bictegravir, amorphous bictegravir sodium, and amorphous solid dispersion of bictegravir sodium with pharmaceutically acceptable carriers, along with the processes for their preparation. Another significant patent involves the amorphous form of trisodium sacubitril valsartan and methods for its preparation, showcasing his expertise in creating advanced pharmaceutical compounds.

Career Highlights

Aggi Ramireddy Bommareddy is currently associated with Mylan Laboratories Limited, a leading global pharmaceutical company. His role at Mylan has allowed him to contribute to the development of innovative drug formulations that address critical health needs.

Collaborations

Throughout his career, Aggi has collaborated with talented professionals, including Ramakoteswara Rao Jetti and Chetan Kanaiyalal Raval. These collaborations have further enriched his research and development efforts in the pharmaceutical sector.

Conclusion

Aggi Ramireddy Bommareddy stands out as a prominent inventor in the pharmaceutical industry, with a focus on innovative drug formulations and processes. His contributions continue to impact the field positively, enhancing the effectiveness of treatments available to patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…